This study is currently recruiting patients.
Sponsored by Cancer Research UK
Biological therapies such as imiquimod use different ways to stimulate the immune system and stop cancer ceils from growing. It is not yet known if topical imiquimod is more effective than surgery in treating basal cell skin cancer. This randomized phase III trial will compare the effectiveness of topical imiquimod with that of surgery in treating patients who have basal cell skin cancer.
Study ID Numbers: CDR0000320513; CRUK-LON-SINS-C7484/A2869; EU-20205
NLM Identifier: NCT00066872
COPYRIGHT 2003 Journal of Drugs in Dermatology
COPYRIGHT 2003 Gale Group
Contact
Home
A
Ibuprofen